FDA Approves First Oral Option for Eosinophilic Esophagitis

(MedPage Today) -- The FDA approved budesonide oral suspension (Eohilia) for adults and children ages 11 years and older with eosinophilic esophagitis (EoE), drugmaker Takeda announced. Approval of the 12-week course of corticosteroids, delivered...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news